Xenetic Biosciences Inc. (XBIO)
Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival
Xenetic Biosciences Showcases Compelling ASCO 2026 Data Demonstrating DNase I Significantly Enhances CAR-T Cell Persistence, Tumor Control, and Survival
Anixa Biosciences Strengthens International Patent Protection for Ovarian Cancer Vaccine Technology with Canadian Notice of Allowance
U Power Hydro Data Joint Venture Receives "Data Center Power & Energy Solution" Recognition at DIF Awards 2026 in Thailand
System1 Strengthens Capital Structure and Reduces Total Debt Through Exchange Transaction With Lenders
Community Health Systems Completes Sale of Four Arkansas Hospitals to Freeman Health System
RCI in Compliance with Nasdaq Periodic Filing Requirement
Lincoln Financial Announces Executive Leadership Transitions
AXS Names East West Bank as Its First Official Business Banking Partner
BlackRock Future Builders Launches $25 Million National RFP to Expand America’s Skilled Trades Workforce
LIBERTY LATIN AMERICA ANNOUNCES KEY DATES REGARDING SPECIAL DIVIDEND OF SERIES A PREFERENCE SHARES TO COMMON SHAREHOLDERS